Stifel Financial’s Niagen Bioscience NAGE Stock Holding History

Stifel Financial’s Portfolio NAGE Stock Details NAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-11,620	Closed	-$18.2K	–	3419
2023 Q2	$18.2K	Buy	+11,620	New	+$17.3K	﹤0.01%	3288

Other funds holding NAGE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return

Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Stifel Financial's NAGE Position: Q3 2023 in Review

Stifel Financial sold out of Niagen Bioscience (NAGE) in Q3 2023, closing a stake of 11,620 shares — an estimated $18.2K sold.

Stifel Financial first reported a position in NAGE in Q2 2023 and held it in 1 quarter. The position peaked at $18.2K in Q2 2023. 54 funds tracked by Wall St. Rank hold NAGE as of Q3 2023.

Stifel Financial reported no remaining Niagen Bioscience position as of Q3 2023 after selling out during the quarter.
Stifel Financial sold 11,620 Niagen Bioscience shares in Q3 2023, an estimated $18.2K.
Stifel Financial first reported a position in Niagen Bioscience in Q2 2023 and held it in 1 quarter.
Stifel Financial's Niagen Bioscience position peaked at $18.2K in Q2 2023.
54 funds tracked by Wall St. Rank held Niagen Bioscience as of Q3 2023.

Based on Stifel Financial's 13F filing for Q3 2023, filed 13 Nov 2023.